Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (111-120 of 176) with videos related to

Pageof 18
Sort By:
The Pharmacogenomics Journal|June 6, 2012
Functional characterization of ABCC2 promoter polymorphisms and allele-specific expressionT D Nguyen, S Markova, W Liu, et al.
Lancet (London, England)|November 9, 2000
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemiaM V Relling, C H Pui, J T Sandlund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemiaM V Relling, H H Mahmoud, C H Pui, et al.
The British Journal of Cancer. Supplement|August 1, 1992
Disposition of antineoplastic agents in the very young childH L McLeod, M V Relling, W R Crom, et al.
Cancer|September 1, 1988
Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusionM V Relling, F B Stapleton, J Ochs, et al.
Blood Cancer Journal|February 18, 2017
The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemiaH M Eissa, Y Zhou, J C Panetta, et al.
Clinical Pharmacokinetics|March 1, 1987
Pharmacokinetics of anticancer drugs in childrenW R Crom, A M Glynn-Barnhart, J H Rodman, et al.
Molecular Pharmacology|July 1, 1997
Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicityA J Galpin, J D Schuetz, E Masson, et al.
Clinical Pharmacology and Therapeutics|October 11, 2017
Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working GroupP C D Bank, K E Caudle, J J Swen, et al.
The Journal of Clinical Investigation|November 1, 1994
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemiaT W Synold, M V Relling, J M Boyett, et al.
Pageof 18

Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
The Pharmacogenomics Journal|June 6, 2012
Functional characterization of ABCC2 promoter polymorphisms and allele-specific expressionT D Nguyen, S Markova, W Liu, et al.
Lancet (London, England)|November 9, 2000
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemiaM V Relling, C H Pui, J T Sandlund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemiaM V Relling, H H Mahmoud, C H Pui, et al.
The British Journal of Cancer. Supplement|August 1, 1992
Disposition of antineoplastic agents in the very young childH L McLeod, M V Relling, W R Crom, et al.
Cancer|September 1, 1988
Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusionM V Relling, F B Stapleton, J Ochs, et al.
Blood Cancer Journal|February 18, 2017
The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemiaH M Eissa, Y Zhou, J C Panetta, et al.
Clinical Pharmacokinetics|March 1, 1987
Pharmacokinetics of anticancer drugs in childrenW R Crom, A M Glynn-Barnhart, J H Rodman, et al.
Molecular Pharmacology|July 1, 1997
Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicityA J Galpin, J D Schuetz, E Masson, et al.
Clinical Pharmacology and Therapeutics|October 11, 2017
Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working GroupP C D Bank, K E Caudle, J J Swen, et al.
The Journal of Clinical Investigation|November 1, 1994
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemiaT W Synold, M V Relling, J M Boyett, et al.
Pageof 18